These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 25544036

  • 1. N-terminal pro-brain natriuretic peptide in acute Kawasaki disease correlates with coronary artery involvement.
    Adjagba PM, Desjardins L, Fournier A, Spigelblatt L, Montigny M, Dahdah N.
    Cardiol Young; 2015 Oct; 25(7):1311-8. PubMed ID: 25544036
    [Abstract] [Full Text] [Related]

  • 2. Increased Pentraxin 3 Levels Correlate With IVIG Responsiveness and Coronary Artery Aneurysm Formation in Kawasaki Disease.
    Kitoh T, Ohara T, Muto T, Okumura A, Baba R, Koizumi Y, Yamagishi Y, Mikamo H, Daigo K, Hamakubo T.
    Front Immunol; 2021 Oct; 12():624802. PubMed ID: 33912155
    [Abstract] [Full Text] [Related]

  • 3. N-terminal pro-brain natriuretic peptide and risk of coronary artery lesions and resistance to intravenous immunoglobulin in Kawasaki disease.
    Yoshimura K, Kimata T, Mine K, Uchiyama T, Tsuji S, Kaneko K.
    J Pediatr; 2013 Jun; 162(6):1205-9. PubMed ID: 23290510
    [Abstract] [Full Text] [Related]

  • 4. N-terminal pro-brain natriuretic peptide can be an adjunctive diagnostic marker of hyper-acute phase of Kawasaki disease.
    Kwon H, Lee JH, Jung JY, Kwak YH, Kim DK, Jung JH, Chang I, Kim K.
    Eur J Pediatr; 2016 Dec; 175(12):1997-2003. PubMed ID: 27798729
    [Abstract] [Full Text] [Related]

  • 5. [Change in plasma N-terminal pro-brain natriuretic peptide in children with Kawasaki disease and its value in clinical practice].
    Zhang QY, Du JB, Chen YH, Li WZ.
    Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):886-90. PubMed ID: 17254452
    [Abstract] [Full Text] [Related]

  • 6. The role of age-specific N-terminal pro-brain natriuretic peptide cutoff values in predicting intravenous immunoglobulin resistance in Kawasaki disease: a prospective cohort study.
    Shao S, Luo C, Zhou K, Hua Y, Wu M, Liu L, Liu X, Wang C.
    Pediatr Rheumatol Online J; 2019 Sep 18; 17(1):65. PubMed ID: 31533770
    [Abstract] [Full Text] [Related]

  • 7. N-terminal pro-brain natriuretic peptide and prediction of coronary artery dilatation in hyperacute phase of Kawasaki disease.
    Jung JY, Ham EM, Kwon H, Kwak YH, Kim DK, Lee JH, Jung JH.
    Am J Emerg Med; 2019 Mar 18; 37(3):468-471. PubMed ID: 29903669
    [Abstract] [Full Text] [Related]

  • 8. Pro-brain natriuretic peptide (ProBNP) levels in North Indian children with Kawasaki disease.
    Reddy M, Singh S, Rawat A, Sharma A, Suri D, Rohit MK.
    Rheumatol Int; 2016 Apr 18; 36(4):551-9. PubMed ID: 26849890
    [Abstract] [Full Text] [Related]

  • 9. Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial.
    Tremoulet AH, Jain S, Jaggi P, Jimenez-Fernandez S, Pancheri JM, Sun X, Kanegaye JT, Kovalchin JP, Printz BF, Ramilo O, Burns JC.
    Lancet; 2014 May 17; 383(9930):1731-8. PubMed ID: 24572997
    [Abstract] [Full Text] [Related]

  • 10. Brain natriuretic peptide levels in Kawasaki disease: a case report.
    Iwashima S, Ishikawa T, Ohzeki T.
    Pediatr Int; 2009 Jun 17; 51(3):415-8. PubMed ID: 19500284
    [No Abstract] [Full Text] [Related]

  • 11. Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.
    Xie T, Wang Y, Fu S, Wang W, Xie C, Zhang Y, Gong F.
    Pediatr Rheumatol Online J; 2017 Mar 21; 15(1):17. PubMed ID: 28320400
    [Abstract] [Full Text] [Related]

  • 12. Value of the N-terminal of prohormone brain natriuretic peptide in diagnosis of Kawasaki disease.
    Ye Q, Shao WX, Shang SQ, Zhou MM.
    Int J Cardiol; 2015 Jan 15; 178():5-7. PubMed ID: 25464207
    [No Abstract] [Full Text] [Related]

  • 13. N-terminal pro-brain natriuretic peptide and high-sensitivity troponin in the evaluation of acute chest pain of uncertain etiology. A PITAGORAS substudy.
    Sanchis J, Bardají A, Bosch X, Loma-Osorio P, Marín F, Sánchez PL, Calvo F, Avanzas P, Hernández C, Serrano S, Carratalá A, Barrabés JA.
    Rev Esp Cardiol (Engl Ed); 2013 Jul 15; 66(7):532-8. PubMed ID: 24776201
    [Abstract] [Full Text] [Related]

  • 14. A Comprehensive Assessment of the Value of Laboratory Indices in Diagnosing Kawasaki Disease.
    Ye Q, Shao WX, Shang SQ, Zhang T, Hu J, Zhang CC.
    Arthritis Rheumatol; 2015 Jul 15; 67(7):1943-50. PubMed ID: 25778686
    [Abstract] [Full Text] [Related]

  • 15. Factors affecting N-terminal pro-brain natriuretic peptide elevation in the acute phase of Kawasaki disease.
    Yanagisawa D, Ayusawa M, Kato M, Watanabe H, Komori A, Abe Y, Nakamura T, Kamiyama H, Takahashi S.
    Pediatr Int; 2016 Nov 15; 58(11):1105-1111. PubMed ID: 26991905
    [Abstract] [Full Text] [Related]

  • 16. N-terminal pro-B-type natriuretic peptide diagnostic algorithm versus American Heart Association algorithm for Kawasaki disease.
    Dionne A, Meloche-Dumas L, Desjardins L, Turgeon J, Saint-Cyr C, Autmizguine J, Spigelblatt L, Fournier A, Dahdah N.
    Pediatr Int; 2017 Mar 15; 59(3):265-270. PubMed ID: 27589358
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of longitudinal and radial left ventricular functions on 2-D and 3-D echocardiography before and after intravenous immunoglobulin in acute Kawasaki disease.
    Hashimoto I, Saitou Y, Sakata N, Shibata K.
    Pediatr Int; 2017 Dec 15; 59(12):1229-1235. PubMed ID: 28892213
    [Abstract] [Full Text] [Related]

  • 18. Natriuretic peptide as an adjunctive diagnostic test in the acute phase of Kawasaki disease.
    Dahdah N, Siles A, Fournier A, Cousineau J, Delvin E, Saint-Cyr C, Spiegelblatt L, Bonny Y, Vartian M, Montigny M.
    Pediatr Cardiol; 2009 Aug 15; 30(6):810-7. PubMed ID: 19365652
    [Abstract] [Full Text] [Related]

  • 19. N-terminal pro-brain natriuretic peptide (NT proBNP) as a predictive indicator of initial intravenous immunoglobulin treatment failure in children with Kawasaki disease: a retrospective study.
    Kim SY, Han MY, Cha SH, Jeon YB.
    Pediatr Cardiol; 2013 Aug 15; 34(8):1837-43. PubMed ID: 23744100
    [Abstract] [Full Text] [Related]

  • 20. N-terminal prob-type natriuretic peptide is a marker of vascular remodelling and subclinical atherosclerosis in asymptomatic hypertensives.
    Pastormerlo LE, Maffei S, Latta DD, Chubuchny V, Susini C, Berti S, Clerico A, Prontera C, Passino C, Januzzi JL, Emdin M, Chiappino D.
    Eur J Prev Cardiol; 2016 Mar 15; 23(4):366-76. PubMed ID: 25644699
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.